Adição na publicação
#15.35
10/13/2021
RPI 2649
Application data
Number
112019012257Type
Filing
Publication
PCT
US2017067400 The application was abandoned: examination was not requested within the 36 months following the 12/19/2017 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/13/2021. We update with every new RPI gazette, published weekly.
Applicants
LA JOLLA PHARMACEUTICAL COMPANY
US
Inventors
G. T. (pessoa física)
US
L. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/436,070 · 12/19/2016
US
62/443,088 · 01/06/2017
US
62/474,347 · 03/21/2017
US
62/527,354 · 06/30/2017
Abstract
A presente invenção refere-se ao uso de hepcidina em métodos terapêuticos para o tratamento de várias condições nas quais pode ser benéfica a diminuição da concentração sérica de ferro.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/13/2021
RPI 2649
#11.1.1
06/15/2021
RPI 2632
#11.1
03/30/2021
RPI 2621
#1.3
12/10/2019
RPI 2553
#1.1
06/25/2019
RPI 2529
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.